CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Import this data to Google Sheets with:

=jivedata("CRL","financials")

Full statements spill as a table. For one cell: =jivedata("CRL","Revenue") or =jivedata("CRL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL • CIK 0001100682

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$4,129,409	$4,049,989	$4,015,382	$3,998,987
Operating Income (Loss)	$617,261	$227,347	$25,162	$90,144
Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax	$581,284	$93,114	$-99,503	$-183,671
Income Tax Expense (Benefit)	$100,914	$67,823	$42,660	$52,625
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$480,370	$25,291	$-142,163	$-236,296
Net Income (Loss) Attributable to Noncontrolling Interest	$5,746	$3,088	$2,175	$2,162
Net Income (Loss) Attributable to Parent	$474,624	$22,203	$-144,338	$-238,458
Selling, General and Administrative Expense	$747,855	$751,003	$743,073	$762,044
Amortization of Intangible Assets	$137,440	$138,471	$179,066	$78,352
Impairment of Intangible Assets, Finite-lived	—	—	$210,974	$210,974
Goodwill, Impairment Loss	$0	$215,000	$165,000	$165,000
Investment Income, Interest	$5,196	$8,575	$4,940	$4,504
InterestExpenseNonoperating	—	$126,288	$107,029	$106,260
Other Nonoperating Income (Expense)	$95,537	$-16,520	$-22,576	$-172,059
Net Income (Loss) Available to Common Stockholders, Basic	—	$10,297	$-144,338	$-144,338
Weighted Average Number of Shares Outstanding, Basic	51,227,000	51,380,000	49,564,000	48,137,000
Weighted Average Number of Shares Outstanding, Diluted	51,451,000	51,628,000	49,564,000	47,961,000
Severance Costs	—	$54,185	$29,010	$25,340
Other Restructuring Costs	—	$52,800	$70,804	$73,066
Restructuring Charges	$29,682	$106,985	$99,814	$98,406

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$276,771	$194,606	$213,770	$192,025
Accounts Receivable, after Allowance for Credit Loss, Current	$780,375	$720,915	$708,856	$711,755
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$1,639,741	$1,604,014	$1,655,219	$1,494,914
Inventory, Net	$380,259	$278,544	$299,103	$346,260
Equity Method Investments	$243,811	$218,350	$206,972	$206,470
Prepaid Expense, Current	$87,879	$103,210	$96,108	$100,409
Operating Lease, Right-of-Use Asset	$394,029	$412,490	$361,415	$330,247
Prepaid Expense and Other Assets, Current	$83,378	$105,796	$129,212	$178,657
Goodwill	$3,095,045	$2,846,608	$2,764,253	$3,076,851
Assets, Current	$1,608,662	$1,403,071	$1,447,049	$1,529,106
Finite-Lived Intangible Assets, Net	$864,051	$723,400	$339,995	$253,174
Deferred Income Tax Assets, Net	$40,279	$42,179	$67,334	$53,827
Other Assets, Noncurrent	$309,383	$278,233	$293,185	$587,556
Assets	$8,195,001	$7,528,345	$7,135,422	$7,532,145
Long-term Debt and Lease Obligation	$2,647,147	$2,240,205	$2,136,360	$2,619,985
Operating Lease, Liability, Noncurrent	$419,234	$483,789	$434,048	$407,708
Deferred Income Tax Liabilities, Net	$191,349	$106,960	$95,203	$78,668
Other Liabilities, Noncurrent	$223,191	$195,212	$138,302	$402,511
Liabilities	$4,536,003	$4,020,267	$3,924,228	$4,643,618
Redeemable Noncontrolling Interest, Equity, Carrying Amount	$56,722	$41,126	$41,263	$42,537
Accounts Payable, Current	$168,937	$140,337	$148,800	$140,983
Employee-related Liabilities, Current	$213,290	$179,418	$268,854	$187,835
Contract with Customer, Liability, Current	$241,820	$248,322	$210,418	$203,035
Accrued Liabilities, Current	$227,825	$232,010	$270,085	$380,101
Other Liabilities, Current	$203,210	$194,014	$222,158	$222,792
Liabilities, Current	$1,055,082	$994,101	$1,120,315	$1,134,746
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$513	$511	$492	$496
Additional Paid in Capital, Common Stock	$1,905,578	$1,966,237	$1,947,301	$1,986,023
Retained Earnings (Accumulated Deficit)	$1,887,218	$1,812,100	$1,388,620	$1,372,295
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-196,427	$-317,345	$-171,783	$-195,989
Stockholders' Equity Attributable to Parent	$3,596,882	$3,461,503	$3,164,630	$2,839,636
Stockholders' Equity Attributable to Noncontrolling Interest	$5,394	$5,449	$5,301	$6,354
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$3,602,276	$3,466,952	$3,169,931	$2,845,990
Accounts Receivable, Allowance for Credit Loss, Current	$25,722	$18,301	$10,463	$8,715
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	120,000,000	120,000,000	120,000,000	120,000,000
Common Stock, Shares, Issued	51,338,000	51,141,000	49,217,000	49,550,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$480,370	$25,291	$-142,163	$-236,296
Net Cash Provided by (Used in) Operating Activities	$683,898	$734,577	$737,646	$582,148
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$8,044	$-17,474	$18,828	$1,361
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$43,266	$-78,910	$10,427	$55,841
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$284,480	$205,570	$215,997	$182,470
Depreciation, Depletion and Amortization	$314,124	$361,741	$403,312	$297,882
Payments to Acquire Productive Assets	$318,528	$232,967	$219,152	$211,543
Goodwill, Impairment Loss	$0	$215,000	$165,000	$165,000
Payments to Acquire Investments	$54,215	$52,876	$20,076	$23,791
Impairment of Long-Lived Assets Held-for-use	$41,911	$51,825	$259,080	$254,156
Payments to Acquire Businesses, Net of Cash Acquired	$194,785	$5,479	$0	$467,254
Share-based Payment Arrangement, Noncash Expense	$72,048	$69,891	$71,083	$83,061
Proceeds from Sale and Maturity of Marketable Securities	$6,667	$41,687	$9,102	$18,055
Deferred Income Taxes and Tax Credits	$-50,903	$-67,428	$-75,292	$-22,185
Proceeds from Sales of Business, Affiliate and Productive Assets	—	—	$17,441	$176,563
Inventory Write-down	—	$46,992	$12,444	$4,542
Payments for (Proceeds from) Other Investing Activities	$2,294	$-4,549	$-3,364	$-1,719
Net Cash Provided by (Used in) Investing Activities	$-563,155	$-245,086	$-209,321	$-506,251
Accounts Receivable, Credit Loss Expense (Reversal)	$18,225	$14,774	$6,062	$4,995
Gain (Loss) on Disposition of Business	$-961	$-659	$3,376	$-117,981
Other Noncash Income (Expense)	$-1,592	$-33,251	$-2,504	$12,357
Proceeds from Issuance of Long-term Debt	$776,353	$1,081,581	$1,227,534	$1,529,429
Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security	$851,676	$1,493,769	$1,349,317	$1,207,538
Proceeds from Stock Options Exercised	$25,597	$23,878	$714	$2,333
Payments for Repurchase of Common Stock	$24,155	$119,175	$360,673	$324,070
Payment for Contingent Consideration Liability, Financing Activities	$2,711	$0	$21,822	$11,400
Proceeds from (Payments for) Other Financing Activities	$-4,145	$-31,442	$-14,022	$-10,171
Net Cash Provided by (Used in) Financing Activities	$-85,521	$-550,927	$-536,726	$-21,417
Increase (Decrease) in Accounts Receivable	$33,434	$-21,612	$-35,737	$32,908
Increase (Decrease) in Inventories	$62,301	$-16,804	$48,777	$-8,923
Increase (Decrease) in Accounts Payable	$-20,427	$-14,271	$2,869	$7,904
Increase (Decrease) in Employee Related Liabilities	$12,447	$-27,604	$79,308	$-24,540
Increase (Decrease) in Contract with Customer, Liability	$-21,743	$18,541	$-38,139	$-43,852
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$-38,642	$51,995	$31,569	$29,696

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CRL","financials")

Full statements spill as a table. For one cell: =jivedata("CRL","Revenue") or =jivedata("CRL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.